Published on 9 Oct 2023 on Simply Wall St. via Yahoo Finance
While institutions invested in ALX Oncology Holdings Inc. (NASDAQ:ALXO) benefited from last week's...
Key Insights
Significant control over ALX Oncology Holdings by private equity firms implies that the general public has more power to influence management and governance-related decisionsA total of 4 investors have a majority stake in the company with 51% ownership Institutions own 38% of ALX Oncology Holdings
To get a sense of who is truly in control of ALX Oncology Holdings Inc. (NASDAQ:ALXO), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 44% to be precise, is private equity firms. Put another way, the group faces the maximum upside potential (or downside risk).